US Stock MarketDetailed Quotes

WMGI Wright Medical

Watchlist
  • 29.980
  • 0.0000.00%
Close Nov 10 16:00 ET
3.90BMarket Cap-35.27P/E (TTM)

Wright Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 27, 2020
(Q2)Jun 28, 2020
(Q1)Mar 29, 2020
(FY)Dec 29, 2019
(Q4)Dec 29, 2019
(Q3)Sep 29, 2019
(Q2)Jun 30, 2019
(Q1)Mar 31, 2019
(FY)Dec 30, 2018
(Q4)Dec 30, 2018
Total revenue
5.15%223.37M
-43.43%129.96M
-5.04%218.54M
10.13%920.9M
4.39%248.61M
9.44%212.43M
11.85%229.73M
15.91%230.13M
12.24%836.19M
9.44%238.15M
Operating revenue
5.15%223.37M
-43.43%129.96M
-5.04%218.54M
10.13%920.9M
4.39%248.61M
9.44%212.43M
11.85%229.73M
15.91%230.13M
12.24%836.19M
9.44%238.15M
Cost of revenue
1.58%45.14M
-40.58%28.72M
-15.98%38.92M
4.71%188.64M
0.81%49.55M
0.30%44.44M
6.10%48.34M
12.59%46.32M
11.93%180.15M
3.96%49.15M
Gross profit
6.09%178.23M
-44.19%101.23M
-2.28%179.63M
11.62%732.26M
5.32%199.06M
12.15%167.99M
13.48%181.4M
16.78%183.81M
12.33%656.04M
10.96%189M
Operating expense
-9.64%161.87M
-21.38%140.51M
2.50%182.31M
8.56%720.67M
-0.09%184.94M
12.71%179.13M
10.67%178.73M
12.37%177.87M
9.95%663.83M
20.90%185.11M
Selling and administrative expenses
-9.82%137.78M
-22.27%118.24M
0.84%154.59M
6.35%614.67M
-2.61%156.47M
9.74%152.78M
8.01%152.11M
11.70%153.31M
10.04%577.96M
20.66%160.66M
Research and development costs
-9.50%16.33M
-24.41%14.18M
15.48%19.6M
25.27%74.09M
21.27%20.31M
30.49%18.05M
27.90%18.76M
22.11%16.97M
18.01%59.14M
27.43%16.75M
Depreciation amortization depletion
-6.66%7.76M
2.91%8.09M
7.08%8.12M
19.42%31.92M
6.04%8.16M
41.27%8.31M
30.84%7.86M
6.25%7.59M
-5.87%26.73M
12.86%7.7M
-Depreciation and amortization
-6.66%7.76M
2.91%8.09M
7.08%8.12M
19.42%31.92M
6.04%8.16M
41.27%8.31M
30.84%7.86M
6.25%7.59M
-5.87%26.73M
12.86%7.7M
Operating profit
246.84%16.36M
-1,573.29%-39.28M
-145.21%-2.69M
248.63%11.59M
263.25%14.12M
-21.96%-11.14M
260.80%2.67M
767.98%5.95M
60.41%-7.8M
-77.42%3.89M
Net non-operating interest income expense
-6.76%-21.83M
-5.91%-21.18M
-3.94%-20.47M
-0.75%-80.85M
-3.53%-20.71M
-3.52%-20.45M
3.30%-20M
0.59%-19.7M
-7.51%-80.25M
-4.56%-20M
Non-operating interest expense
6.76%21.83M
5.91%21.18M
3.94%20.47M
0.75%80.85M
3.53%20.71M
3.52%20.45M
-3.30%20M
-0.59%19.7M
7.51%80.25M
4.56%20M
Other net income (expense)
-671.60%-10.16M
307.54%7.46M
206.30%13.71M
87.89%-9.9M
140.29%2.48M
66.25%-1.32M
102.52%1.83M
-1,389.50%-12.9M
-1,368.53%-81.8M
-571.11%-6.15M
Other non- operating income (expenses)
-671.60%-10.16M
307.54%7.46M
206.30%13.71M
87.89%-9.9M
140.29%2.48M
66.25%-1.32M
102.52%1.83M
-1,389.50%-12.9M
-1,368.53%-81.8M
-571.11%-6.15M
Income before tax
52.48%-15.64M
-241.93%-52.99M
64.53%-9.45M
53.39%-79.17M
81.51%-4.12M
-0.35%-32.91M
83.70%-15.5M
-35.24%-26.65M
-70.00%-169.84M
-3,502.91%-22.27M
Income tax
-60.49%1.3M
-100.32%-11K
-40.79%2.14M
2,519.40%12.97M
285.90%2.63M
8.39%3.3M
176.96%3.43M
1,661.46%3.61M
98.47%-536K
102.48%681K
Net income
54.96%-19.72M
-233.44%-59.39M
59.27%-14.91M
32.61%-114.23M
52.55%-16.02M
-2.97%-43.79M
73.69%-17.81M
-43.45%-36.6M
16.33%-169.51M
-215.91%-33.77M
Net income continuous Operations
53.21%-16.94M
-179.85%-52.98M
61.70%-11.59M
45.58%-92.13M
70.60%-6.75M
-1.04%-36.2M
79.11%-18.93M
-51.99%-30.26M
-160.72%-169.3M
-185.46%-22.95M
Net income discontinuous operations
63.30%-2.79M
-672.50%-6.41M
47.72%-3.32M
-10,890.55%-22.09M
14.27%-9.28M
-13.34%-7.59M
-95.11%1.12M
-13.16%-6.35M
99.85%-201K
-574.40%-10.82M
Minority interest income
Net income attributable to the parent company
54.96%-19.72M
-233.44%-59.39M
59.27%-14.91M
32.61%-114.23M
52.55%-16.02M
-2.97%-43.79M
73.69%-17.81M
-43.45%-36.6M
16.33%-169.51M
-215.91%-33.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
54.96%-19.72M
-233.44%-59.39M
59.27%-14.91M
32.61%-114.23M
52.55%-16.02M
-2.97%-43.79M
73.69%-17.81M
-43.45%-36.6M
16.33%-169.51M
-215.91%-33.77M
Basic earnings per share
57.14%-0.15
-228.57%-0.46
58.62%-0.12
40.40%-0.9
55.56%-0.12
7.89%-0.35
78.13%-0.14
-20.83%-0.29
22.16%-1.51
-196.43%-0.27
Diluted earnings per share
57.14%-0.15
-228.57%-0.46
58.62%-0.12
40.40%-0.9
55.56%-0.12
7.89%-0.35
78.13%-0.14
-20.37%-0.29
22.16%-1.51
-200.00%-0.27
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 27, 2020(Q2)Jun 28, 2020(Q1)Mar 29, 2020(FY)Dec 29, 2019(Q4)Dec 29, 2019(Q3)Sep 29, 2019(Q2)Jun 30, 2019(Q1)Mar 31, 2019(FY)Dec 30, 2018(Q4)Dec 30, 2018
Total revenue 5.15%223.37M-43.43%129.96M-5.04%218.54M10.13%920.9M4.39%248.61M9.44%212.43M11.85%229.73M15.91%230.13M12.24%836.19M9.44%238.15M
Operating revenue 5.15%223.37M-43.43%129.96M-5.04%218.54M10.13%920.9M4.39%248.61M9.44%212.43M11.85%229.73M15.91%230.13M12.24%836.19M9.44%238.15M
Cost of revenue 1.58%45.14M-40.58%28.72M-15.98%38.92M4.71%188.64M0.81%49.55M0.30%44.44M6.10%48.34M12.59%46.32M11.93%180.15M3.96%49.15M
Gross profit 6.09%178.23M-44.19%101.23M-2.28%179.63M11.62%732.26M5.32%199.06M12.15%167.99M13.48%181.4M16.78%183.81M12.33%656.04M10.96%189M
Operating expense -9.64%161.87M-21.38%140.51M2.50%182.31M8.56%720.67M-0.09%184.94M12.71%179.13M10.67%178.73M12.37%177.87M9.95%663.83M20.90%185.11M
Selling and administrative expenses -9.82%137.78M-22.27%118.24M0.84%154.59M6.35%614.67M-2.61%156.47M9.74%152.78M8.01%152.11M11.70%153.31M10.04%577.96M20.66%160.66M
Research and development costs -9.50%16.33M-24.41%14.18M15.48%19.6M25.27%74.09M21.27%20.31M30.49%18.05M27.90%18.76M22.11%16.97M18.01%59.14M27.43%16.75M
Depreciation amortization depletion -6.66%7.76M2.91%8.09M7.08%8.12M19.42%31.92M6.04%8.16M41.27%8.31M30.84%7.86M6.25%7.59M-5.87%26.73M12.86%7.7M
-Depreciation and amortization -6.66%7.76M2.91%8.09M7.08%8.12M19.42%31.92M6.04%8.16M41.27%8.31M30.84%7.86M6.25%7.59M-5.87%26.73M12.86%7.7M
Operating profit 246.84%16.36M-1,573.29%-39.28M-145.21%-2.69M248.63%11.59M263.25%14.12M-21.96%-11.14M260.80%2.67M767.98%5.95M60.41%-7.8M-77.42%3.89M
Net non-operating interest income expense -6.76%-21.83M-5.91%-21.18M-3.94%-20.47M-0.75%-80.85M-3.53%-20.71M-3.52%-20.45M3.30%-20M0.59%-19.7M-7.51%-80.25M-4.56%-20M
Non-operating interest expense 6.76%21.83M5.91%21.18M3.94%20.47M0.75%80.85M3.53%20.71M3.52%20.45M-3.30%20M-0.59%19.7M7.51%80.25M4.56%20M
Other net income (expense) -671.60%-10.16M307.54%7.46M206.30%13.71M87.89%-9.9M140.29%2.48M66.25%-1.32M102.52%1.83M-1,389.50%-12.9M-1,368.53%-81.8M-571.11%-6.15M
Other non- operating income (expenses) -671.60%-10.16M307.54%7.46M206.30%13.71M87.89%-9.9M140.29%2.48M66.25%-1.32M102.52%1.83M-1,389.50%-12.9M-1,368.53%-81.8M-571.11%-6.15M
Income before tax 52.48%-15.64M-241.93%-52.99M64.53%-9.45M53.39%-79.17M81.51%-4.12M-0.35%-32.91M83.70%-15.5M-35.24%-26.65M-70.00%-169.84M-3,502.91%-22.27M
Income tax -60.49%1.3M-100.32%-11K-40.79%2.14M2,519.40%12.97M285.90%2.63M8.39%3.3M176.96%3.43M1,661.46%3.61M98.47%-536K102.48%681K
Net income 54.96%-19.72M-233.44%-59.39M59.27%-14.91M32.61%-114.23M52.55%-16.02M-2.97%-43.79M73.69%-17.81M-43.45%-36.6M16.33%-169.51M-215.91%-33.77M
Net income continuous Operations 53.21%-16.94M-179.85%-52.98M61.70%-11.59M45.58%-92.13M70.60%-6.75M-1.04%-36.2M79.11%-18.93M-51.99%-30.26M-160.72%-169.3M-185.46%-22.95M
Net income discontinuous operations 63.30%-2.79M-672.50%-6.41M47.72%-3.32M-10,890.55%-22.09M14.27%-9.28M-13.34%-7.59M-95.11%1.12M-13.16%-6.35M99.85%-201K-574.40%-10.82M
Minority interest income
Net income attributable to the parent company 54.96%-19.72M-233.44%-59.39M59.27%-14.91M32.61%-114.23M52.55%-16.02M-2.97%-43.79M73.69%-17.81M-43.45%-36.6M16.33%-169.51M-215.91%-33.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 54.96%-19.72M-233.44%-59.39M59.27%-14.91M32.61%-114.23M52.55%-16.02M-2.97%-43.79M73.69%-17.81M-43.45%-36.6M16.33%-169.51M-215.91%-33.77M
Basic earnings per share 57.14%-0.15-228.57%-0.4658.62%-0.1240.40%-0.955.56%-0.127.89%-0.3578.13%-0.14-20.83%-0.2922.16%-1.51-196.43%-0.27
Diluted earnings per share 57.14%-0.15-228.57%-0.4658.62%-0.1240.40%-0.955.56%-0.127.89%-0.3578.13%-0.14-20.37%-0.2922.16%-1.51-200.00%-0.27
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.